Heart Failure Progression in Hypertrophic Cardiomyopathy　– Possible Insights From Cardiopulmonary Exercise Testing

Heart Failure Progression in Hypertrophic Cardiomyopathy　– Possible Insights From Cardiopulmonary Exercise Testing –

Published:2016 Issue:10 Volume:80 Page:2204-2211
ISSN:1346-9843
Container-title:Circulation Journal
language:en
Short-container-title:Circ J

Author:

Magrì Damiano¹,Re Federica²,Limongelli Giuseppe³,Agostoni Piergiuseppe⁴⁵,Zachara Elisabetta²,Correale Michele⁶,Mastromarino Vittoria¹,Santolamazza Caterina¹,Casenghi Matteo¹,Pacileo Giuseppe³,Valente Fabio³,Morosin Marco⁴⁷,Musumeci Beatrice¹,Pagannone Erika¹,Maruotti Antonello⁸⁹,Uguccioni Massimo²,Volpe Massimo¹¹⁰,Autore Camillo¹

Affiliation:

1. Department of Clinical and Molecular Medicine, University of Rome “La Sapienza”

2. Cardiology Division, Cardiac Arrhythmia Center and Cardiomyopathies Unit, San Camillo–Forlanini Hospital

3. Cardiology SUN, Monaldi Hospital, II University of Naples

4. “Monzino” Cardiologic Center, IRCCS

5. Department of Clinical Sciences and Community Health, University of Milan

6. Department of Cardiology, University of Foggia

7. Cardiovascular Department, “Ospedali Riuniti” Trieste and Postgraduate School Cardiovascular Sciences, University of Trieste

8. Department of Economic, Political Sciences and Modern Languages “Libera Università-SS Maria Assunta”

9. Centre for Innovation and Leadership in Health Sciences, University of Southampton

10. IRCCS–Neuromed

Publisher

Japanese Circulation Society

Subject

Cardiology and Cardiovascular Medicine,General Medicine

Link

https://www.jstage.jst.go.jp/article/circj/80/10/80_CJ-16-0432/_pdf

Reference40 articles.

1. 1. Maron BJ, Maron MS. Hypertrophic cardiomyopathy. Lancet 2013; 381: 242–255.

2. 2. Maron BJ. Risk stratification and role of implantable defibrillators for prevention of sudden death in patients with hypertrophic cardiomyopathy. Circ J 2010; 74: 2271–2282.

3. 3. O’Mahony C, Jichi F, Pavlou M, Monserrat L, Anastasakis A, Rapezzi C, et al; Hypertrophic Cardiomyopathy Outcomes Investigators. A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM Risk-SCD). Eur Heart J 2014; 35: 2010–2020.

4. 4. Gersh BJ, Maron BJ, Bonow RO, Dearani JA, Fifer MA, Link MS, et al. 2011 ACCF/AHA Guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: Executive summary: A report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2011; 124: 2761–2796.

5. 5. Authors/Task Force members,Elliott PM, Anastasakis A, Borger MA, Borggrefe M, Cecchi F, Charron P, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: The Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J 2014; 35: 2733–2779.

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exercise Capacity in Patients With Obstructive Hypertrophic Cardiomyopathy;JACC: Heart Failure;2024-01

2. Three-dimensional echocardiography for the evaluation of hypertrophic cardiomyopathy patients: relation to symptoms and exercise capacity;The International Journal of Cardiovascular Imaging;2023-10-11

3. The cardiopulmonary exercise test in the prognostic evaluation of patients with heart failure and cardiomyopathies: the long history of making a one-size-fits-all suit;European Journal of Preventive Cardiology;2023-10

4. Fibrosis-specific biomarkers and interstitial fibrosis in hypertrophic cardiomyopathy;Kardiologia Polska;2023-08-26

5. The Role of Cardiopulmonary Exercise Testing in Hypertrophic Cardiomyopathy;Medicina;2023-07-13